Hospital Universitario y Politecnico La Fe-merge

Valencia 46026

0 studies enrolling now · 2 studies all time

What they study most

Cutaneous Squamous Cell Carcinoma, Fibrodysplasia Ossificans Progressiva

Studies at this site

• A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). — Stopped early
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling